(PharmaNewsWire.Com, October 11, 2018 ) GlobalData's clinical trial report, “Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2018" provides an overview of Skin And Skin Structure Infections (SSSI) Caused By Bacteria clinical trials scenario. This report provides top line data relating to the clinical trials on Skin And Skin Structure Infections (SSSI) Caused By Bacteria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Key Players: • Novartis AG • Allergan Plc • Merck & Co Inc • Wockhardt Ltd • Melinta Therapeutics Inc • Pharmaceutical Product Development LLC • The Medicines Company • Debiopharm Group • AstraZeneca Plc • GlaxoSmithKline Plc
Scope: - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months
Reasons to buy: - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level
Key Points from TOC: Report Guidance 6 GlobalData Clinical Trials Report Coverage 7 Clinical Trials by Region 8 Clinical Trials and Average Enrollment by Country 9 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by G7 Countries: Proportion of Skin And Skin Structure Infections (SSSI) Caused By Bacteria to Infectious Disease Clinical Trials 17 Clinical Trials by Phase in G7 Countries 19 Clinical Trials in G7 Countries by Trial Status 20 Clinical Trials by E7 Countries: Proportion of Skin And Skin Structure Infections (SSSI) Caused By Bacteria to Infectious Disease Clinical Trials 21 Clinical Trials by Phase in E7 Countries 23 Clinical Trials in E7 Countries by Trial Status 24 Clinical Trials by Phase 25 In Progress Trials by Phase 26 Clinical Trials by Trial Status 27 Clinical Trials by End Point Status 28 Subjects Recruited Over a Period of Time 29 Clinical Trials by Sponsor Type 30 Prominent Sponsors 31 Top Companies Participating in Skin And Skin Structure Infections (SSSI) Caused By Bacteria Therapeutics Clinical Trials 33 Prominent Drugs 35 Latest Clinical Trials News on Skin And Skin Structure Infections (SSSI) Caused By Bacteria 37 Jun 11, 2018: Motif Bio Announces New Iclaprim Data Presented at ASM Microbe 2018 37 Jun 07, 2018: Paratek Demonstrates Breadth of Omadacycline Clinical and Microbiological Data at ASM Microbe 2018 37 May 31, 2018: Nabriva Therapeutics to Present Lefamulin Data at ASM Microbe 37 May 31, 2018: Melinta Therapeutics Demonstrates Presentations on Baxdela at ASM Microbe 2018 38 Clinical Trial Profile Snapshots 39 Continued….
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
